nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—Altered state of consciousness—Vandetanib—thyroid cancer	0.0873	0.0873	CcSEcCtD
Cyclizine—Depressed level of consciousness—Vandetanib—thyroid cancer	0.0389	0.0389	CcSEcCtD
Cyclizine—Dermatitis bullous—Vandetanib—thyroid cancer	0.0306	0.0306	CcSEcCtD
Cyclizine—Bronchospasm—Vandetanib—thyroid cancer	0.0249	0.0249	CcSEcCtD
Cyclizine—Hepatic function abnormal—Sorafenib—thyroid cancer	0.0226	0.0226	CcSEcCtD
Cyclizine—Hepatobiliary disease—Vandetanib—thyroid cancer	0.0213	0.0213	CcSEcCtD
Cyclizine—Eye disorder—Vandetanib—thyroid cancer	0.0189	0.0189	CcSEcCtD
Cyclizine—Mental disorder—Vandetanib—thyroid cancer	0.0177	0.0177	CcSEcCtD
Cyclizine—Muscle spasms—Vandetanib—thyroid cancer	0.0169	0.0169	CcSEcCtD
Cyclizine—Vision blurred—Vandetanib—thyroid cancer	0.0166	0.0166	CcSEcCtD
Cyclizine—Tremor—Vandetanib—thyroid cancer	0.0165	0.0165	CcSEcCtD
Cyclizine—Convulsion—Vandetanib—thyroid cancer	0.0153	0.0153	CcSEcCtD
Cyclizine—Hypertension—Vandetanib—thyroid cancer	0.0152	0.0152	CcSEcCtD
Cyclizine—Hepatobiliary disease—Sorafenib—thyroid cancer	0.0144	0.0144	CcSEcCtD
Cyclizine—Nervous system disorder—Vandetanib—thyroid cancer	0.0141	0.0141	CcSEcCtD
Cyclizine—Skin disorder—Vandetanib—thyroid cancer	0.014	0.014	CcSEcCtD
Cyclizine—Blister—Epirubicin—thyroid cancer	0.0139	0.0139	CcSEcCtD
Cyclizine—Connective tissue disorder—Sorafenib—thyroid cancer	0.0134	0.0134	CcSEcCtD
Cyclizine—Insomnia—Vandetanib—thyroid cancer	0.013	0.013	CcSEcCtD
Cyclizine—Paraesthesia—Vandetanib—thyroid cancer	0.0129	0.0129	CcSEcCtD
Cyclizine—Blister—Doxorubicin—thyroid cancer	0.0129	0.0129	CcSEcCtD
Cyclizine—Pain—Vandetanib—thyroid cancer	0.0123	0.0123	CcSEcCtD
Cyclizine—Constipation—Vandetanib—thyroid cancer	0.0123	0.0123	CcSEcCtD
Cyclizine—Mental disorder—Sorafenib—thyroid cancer	0.012	0.012	CcSEcCtD
Cyclizine—Erythema—Sorafenib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Cyclizine—Jaundice cholestatic—Epirubicin—thyroid cancer	0.0114	0.0114	CcSEcCtD
Cyclizine—Muscle spasms—Sorafenib—thyroid cancer	0.0114	0.0114	CcSEcCtD
Cyclizine—Angioedema—Sorafenib—thyroid cancer	0.0109	0.0109	CcSEcCtD
Cyclizine—Dyskinesia—Epirubicin—thyroid cancer	0.0107	0.0107	CcSEcCtD
Cyclizine—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.0106	0.0106	CcSEcCtD
Cyclizine—Asthenia—Vandetanib—thyroid cancer	0.0103	0.0103	CcSEcCtD
Cyclizine—Hypertension—Sorafenib—thyroid cancer	0.0103	0.0103	CcSEcCtD
Cyclizine—Pruritus—Vandetanib—thyroid cancer	0.0102	0.0102	CcSEcCtD
Cyclizine—Injection site reaction—Epirubicin—thyroid cancer	0.00999	0.00999	CcSEcCtD
Cyclizine—Dyskinesia—Doxorubicin—thyroid cancer	0.00989	0.00989	CcSEcCtD
Cyclizine—Anaphylactic shock—Sorafenib—thyroid cancer	0.0097	0.0097	CcSEcCtD
Cyclizine—Nervous system disorder—Sorafenib—thyroid cancer	0.00951	0.00951	CcSEcCtD
Cyclizine—Dizziness—Vandetanib—thyroid cancer	0.00951	0.00951	CcSEcCtD
Cyclizine—Skin disorder—Sorafenib—thyroid cancer	0.00942	0.00942	CcSEcCtD
Cyclizine—Injection site reaction—Doxorubicin—thyroid cancer	0.00924	0.00924	CcSEcCtD
Cyclizine—Headache—Vandetanib—thyroid cancer	0.00901	0.00901	CcSEcCtD
Cyclizine—Thrombophlebitis—Epirubicin—thyroid cancer	0.00843	0.00843	CcSEcCtD
Cyclizine—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00835	0.00835	CcSEcCtD
Cyclizine—Constipation—Sorafenib—thyroid cancer	0.00829	0.00829	CcSEcCtD
Cyclizine—Pain—Sorafenib—thyroid cancer	0.00829	0.00829	CcSEcCtD
Cyclizine—Thrombophlebitis—Doxorubicin—thyroid cancer	0.0078	0.0078	CcSEcCtD
Cyclizine—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00772	0.00772	CcSEcCtD
Cyclizine—Urticaria—Sorafenib—thyroid cancer	0.00771	0.00771	CcSEcCtD
Cyclizine—Dermatitis bullous—Epirubicin—thyroid cancer	0.00763	0.00763	CcSEcCtD
Cyclizine—Hypersensitivity—Sorafenib—thyroid cancer	0.00715	0.00715	CcSEcCtD
Cyclizine—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00706	0.00706	CcSEcCtD
Cyclizine—Asthenia—Sorafenib—thyroid cancer	0.00696	0.00696	CcSEcCtD
Cyclizine—Pruritus—Sorafenib—thyroid cancer	0.00686	0.00686	CcSEcCtD
Cyclizine—Dizziness—Sorafenib—thyroid cancer	0.00641	0.00641	CcSEcCtD
Cyclizine—Headache—Sorafenib—thyroid cancer	0.00608	0.00608	CcSEcCtD
Cyclizine—Drowsiness—Epirubicin—thyroid cancer	0.00562	0.00562	CcSEcCtD
Cyclizine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00532	0.00532	CcSEcCtD
Cyclizine—Agranulocytosis—Epirubicin—thyroid cancer	0.00525	0.00525	CcSEcCtD
Cyclizine—Drowsiness—Doxorubicin—thyroid cancer	0.0052	0.0052	CcSEcCtD
Cyclizine—Hepatitis—Epirubicin—thyroid cancer	0.00505	0.00505	CcSEcCtD
Cyclizine—Connective tissue disorder—Epirubicin—thyroid cancer	0.00496	0.00496	CcSEcCtD
Cyclizine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00492	0.00492	CcSEcCtD
Cyclizine—Agranulocytosis—Doxorubicin—thyroid cancer	0.00485	0.00485	CcSEcCtD
Cyclizine—Eye disorder—Epirubicin—thyroid cancer	0.00472	0.00472	CcSEcCtD
Cyclizine—Hepatitis—Doxorubicin—thyroid cancer	0.00467	0.00467	CcSEcCtD
Cyclizine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00459	0.00459	CcSEcCtD
Cyclizine—Chills—Epirubicin—thyroid cancer	0.00453	0.00453	CcSEcCtD
Cyclizine—Mental disorder—Epirubicin—thyroid cancer	0.00442	0.00442	CcSEcCtD
Cyclizine—Erythema—Epirubicin—thyroid cancer	0.00439	0.00439	CcSEcCtD
Cyclizine—Eye disorder—Doxorubicin—thyroid cancer	0.00436	0.00436	CcSEcCtD
Cyclizine—Tension—Epirubicin—thyroid cancer	0.00431	0.00431	CcSEcCtD
Cyclizine—Nervousness—Epirubicin—thyroid cancer	0.00427	0.00427	CcSEcCtD
Cyclizine—Muscle spasms—Epirubicin—thyroid cancer	0.00422	0.00422	CcSEcCtD
Cyclizine—Chills—Doxorubicin—thyroid cancer	0.00419	0.00419	CcSEcCtD
Cyclizine—Vision blurred—Epirubicin—thyroid cancer	0.00414	0.00414	CcSEcCtD
Cyclizine—Mental disorder—Doxorubicin—thyroid cancer	0.00409	0.00409	CcSEcCtD
Cyclizine—Erythema—Doxorubicin—thyroid cancer	0.00406	0.00406	CcSEcCtD
Cyclizine—Agitation—Epirubicin—thyroid cancer	0.00404	0.00404	CcSEcCtD
Cyclizine—Tension—Doxorubicin—thyroid cancer	0.00399	0.00399	CcSEcCtD
Cyclizine—Nervousness—Doxorubicin—thyroid cancer	0.00395	0.00395	CcSEcCtD
Cyclizine—Muscle spasms—Doxorubicin—thyroid cancer	0.00391	0.00391	CcSEcCtD
Cyclizine—Vision blurred—Doxorubicin—thyroid cancer	0.00383	0.00383	CcSEcCtD
Cyclizine—Convulsion—Epirubicin—thyroid cancer	0.00381	0.00381	CcSEcCtD
Cyclizine—Hypertension—Epirubicin—thyroid cancer	0.00379	0.00379	CcSEcCtD
Cyclizine—Agitation—Doxorubicin—thyroid cancer	0.00373	0.00373	CcSEcCtD
Cyclizine—Anaphylactic shock—Epirubicin—thyroid cancer	0.00358	0.00358	CcSEcCtD
Cyclizine—Convulsion—Doxorubicin—thyroid cancer	0.00352	0.00352	CcSEcCtD
Cyclizine—Nervous system disorder—Epirubicin—thyroid cancer	0.00352	0.00352	CcSEcCtD
Cyclizine—Hypertension—Doxorubicin—thyroid cancer	0.00351	0.00351	CcSEcCtD
Cyclizine—Tachycardia—Epirubicin—thyroid cancer	0.0035	0.0035	CcSEcCtD
Cyclizine—Skin disorder—Epirubicin—thyroid cancer	0.00348	0.00348	CcSEcCtD
Cyclizine—Hypotension—Epirubicin—thyroid cancer	0.00335	0.00335	CcSEcCtD
Cyclizine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00332	0.00332	CcSEcCtD
Cyclizine—Nervous system disorder—Doxorubicin—thyroid cancer	0.00325	0.00325	CcSEcCtD
Cyclizine—Insomnia—Epirubicin—thyroid cancer	0.00324	0.00324	CcSEcCtD
Cyclizine—Tachycardia—Doxorubicin—thyroid cancer	0.00324	0.00324	CcSEcCtD
Cyclizine—Skin disorder—Doxorubicin—thyroid cancer	0.00322	0.00322	CcSEcCtD
Cyclizine—Paraesthesia—Epirubicin—thyroid cancer	0.00322	0.00322	CcSEcCtD
Cyclizine—Somnolence—Epirubicin—thyroid cancer	0.00319	0.00319	CcSEcCtD
Cyclizine—Hypotension—Doxorubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Cyclizine—Constipation—Epirubicin—thyroid cancer	0.00307	0.00307	CcSEcCtD
Cyclizine—Pain—Epirubicin—thyroid cancer	0.00307	0.00307	CcSEcCtD
Cyclizine—Insomnia—Doxorubicin—thyroid cancer	0.003	0.003	CcSEcCtD
Cyclizine—Paraesthesia—Doxorubicin—thyroid cancer	0.00298	0.00298	CcSEcCtD
Cyclizine—Somnolence—Doxorubicin—thyroid cancer	0.00295	0.00295	CcSEcCtD
Cyclizine—Urticaria—Epirubicin—thyroid cancer	0.00285	0.00285	CcSEcCtD
Cyclizine—Pain—Doxorubicin—thyroid cancer	0.00284	0.00284	CcSEcCtD
Cyclizine—Constipation—Doxorubicin—thyroid cancer	0.00284	0.00284	CcSEcCtD
Cyclizine—Hypersensitivity—Epirubicin—thyroid cancer	0.00264	0.00264	CcSEcCtD
Cyclizine—Urticaria—Doxorubicin—thyroid cancer	0.00263	0.00263	CcSEcCtD
Cyclizine—Asthenia—Epirubicin—thyroid cancer	0.00257	0.00257	CcSEcCtD
Cyclizine—Pruritus—Epirubicin—thyroid cancer	0.00254	0.00254	CcSEcCtD
Cyclizine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00244	0.00244	CcSEcCtD
Cyclizine—Asthenia—Doxorubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Cyclizine—Dizziness—Epirubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Cyclizine—Pruritus—Doxorubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Cyclizine—Headache—Epirubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Cyclizine—Dizziness—Doxorubicin—thyroid cancer	0.00219	0.00219	CcSEcCtD
Cyclizine—Headache—Doxorubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
